Latest Financial Management News

Block, Inc. reported a robust Q1 2026 with AI-powered productivity gains, strong Cash App and Square growth, and a $5 billion share buyback boost. Despite a GAAP net loss due to restructuring and legal costs, the fintech giant raised its full-year outlook, signaling confidence in its AI-led transformation.

Multistack International reversed a $1.68 million loss to report a $2.26 million profit in 2025, driven by $4 million in settlement and asset disposal income. The company plans to exit its loss-making Australian operations through a share disposal while exploring new business avenues.

Forte Energy has rapidly expanded its oil and gas exploration portfolio in Alaska’s National Petroleum Reserve, acquiring over 156,000 acres including the billion-barrel Harrier Prospect and adjacent leases to Umiat Oil Field, while securing significant cost savings through lease fee suspensions.

Gibb River Diamonds (ASX:GIB) has completed mining and processing at its Neta JV within the Edjudina Gold Project, generating over 5,200 ounces of gold and receiving a $7 million profit share. The company is progressing exploration on a new lease near Neta and maintains a strong cash position to support further growth.

Strata Minerals delivered strong maiden drilling results at its Zelica Gold Project, confirming consistent shallow high-grade gold mineralisation over a 1km strike. The company consolidated its landholding with the acquisition of Zelica South, extending the gold corridor to 10km and commencing follow-up exploration.

Li-S Energy secured $1.9 million from ARENA to fund a feasibility study scaling production to 1 GWh, expanded its Battery Testing Centre, and delivered its first drone battery pack under a government program, while progressing key transport certifications.

Janus Electric has begun generating export revenue in the US while expanding its electric truck fleet to 28 vehicles and significantly improving its cash position through a $1.4 million R&D tax refund and a $2.75 million finance facility.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Anagenics Limited delivered a third quarter operational performance aligned with budget following its restructuring, with cash outflows narrowing and its Bouf Haircare brand generating robust royalty revenue.

Hamelin Gold is gearing up for a busy 2026 with planned drilling across three key Western Australian gold provinces, underpinned by a solid cash position and strategic asset sales.

Wellnex Life has pushed back the repayment deadline on nearly $3 million owed to former directors by three months, agreeing to additional fees and interest. Former CEO Zack Bozinovski returns as a consultant, suggesting ongoing strategic recalibration.